极罕见的遗传性代谢和退行性神经系统疾病的纵向研究。
Clinical, Instrumental and Laboratory Data Collection of Subjects With Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.
研究概览
详细说明
The study provides a collection of retrospective data from adult patients with ultra-rare inherited neurological diseases followed at "Carlo Besta" Neurological Institute from 1st January 2004 until March 2021. Further, prospective data will be collected starting from March 2021 (date of protocol approval) and spanning the next ten years. Normal clinical practice will be followed for collection of the prospective data. Follow-up assessment will be performed at least once a year to evaluate the disease course. Based on their clinical manifestations, patients will be assessed by using quantitative functional tests (clinimetric tests such as Timed Up and Go Test) and traditional ordinal scales (such as the scale for the assessment and rating of ataxia (SARA). Moreover, a varying of laboratory and instrumental tests (e.g., neuroimaging, neurophysiological investigations, etc.) will be used according to clinical practice in selected patients.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Renato Mantegazza, MD
- 电话号码:2321 +39022394
- 邮箱:crc@istituto-besta.it
研究联系人备份
- 姓名:Ettore Salsano, MD
- 电话号码:3001 +39022394
- 邮箱:ettore.salsano@istituto-besta.it
学习地点
-
-
Milano
-
Milan、Milano、意大利、20133
- 招聘中
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
接触:
- Elena Mauro, MD
- 电话号码:2388 +39022394
- 邮箱:elena.mauro@istituto-besta.it
-
首席研究员:
- Ettore Salsano, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adults with ultra-rare inherited degenerative and metabolic neurological diseases
Adults with undiagnosed neurological diseases (when supposed to be inherited)
描述
Inclusion Criteria:
- Age >= 18 years
- Subjects with ultra-rare inherited degenerative and metabolic neurological diseases
- Subjects with undiagnosed neurological diseases (when supposed to be inherited)
Exclusion Criteria:
- none
学习计划
研究是如何设计的?
设计细节
- 观测模型:OTHER
- 时间观点:OTHER
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Retrospective study
collection of retrospective data from adult patients with ultra-rare inherited neurological diseases |
collection of retrospective and prospective data from adult patients with ultra-rare inherited neurological diseases |
|
Prospective study
prospective data will be collected starting from March 2021 (date of protocol approval) and spanning the next ten years |
collection of retrospective and prospective data from adult patients with ultra-rare inherited neurological diseases |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Verbal (letter) fluency
大体时间:10 years
|
Repeated Montreal Cognitive Assessment (MoCA) letter F fluency subtest |
10 years
|
|
Stance and gait performances [Time Frame: 10 years] Stance and gait performances
大体时间:10 years
|
Repeated SARA (Scale for the Assessment and Rating Ataxia) stance subtask, ambulation index (AI) and Timed Up and Go (TUG) test |
10 years
|
|
Upper limb motor function
大体时间:10 years
|
Repeated ONLS (Overall Neuropathy Limitation Scale) arm scale |
10 years
|
|
Swallowing function (dysphagia)
大体时间:10 years
|
Repeated NP-C mDRS (Niemann-Pick type C modified disability rating scale) swallowing scale |
10 years
|
|
Speech function (dysarthria)
大体时间:10 years
|
Repeated NP-C mDRS language scale |
10 years
|
|
Bladder function
大体时间:10 years
|
Repeated AADS (Adult Adrenoleukodystrophy Disability Score) Bladder function scale |
10 years
|
|
Sleep
大体时间:10 years
|
Repeated assessment of presence or absence of sleep disturbances |
10 years
|
|
Quality of life
大体时间:10 years
|
Repeated EuroQol-5D-5L (EQ-5D-5L) questionnaire |
10 years
|
合作者和调查者
出版物和有用的链接
一般刊物
- Benzoni C, Moscatelli M, Lanteri P, Pensato V, Calo C, Allievi S, Gellera C, Ardissone A, Moroni I, Fenu S, Cavalca E, Pareyson D, Salsano E. Adrenoleukodystrophy in adults: phenotypic characterisation and natural history in a large cohort. J Neurol Neurosurg Psychiatry. 2026 May 14;97(6):483-492. doi: 10.1136/jnnp-2025-337540.
- Moscatelli M, Benzoni C, Doniselli FM, Verri M, Pascuzzo R, Aquino D, Mazzi F, Erbetta A, Salsano E. Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation. Eur Radiol Exp. 2023 Oct 2;7(1):57. doi: 10.1186/s41747-023-00373-6.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
- 鞘脂增多症
- 脑白质营养不良,
- 肾上腺脑白质营养不良,
- 异染性脑白质营养不良,
- 克拉伯病,
- 消失的白质综合症,
- 亚历山大病,
- 球状体遗传性脑白质营养不良(CSF1R 相关 HLDS),
- Nasu-Hakola 病(TREM2 和 TYROBP 相关疾病)
- 白质脑病,进行性,伴有卵巢功能衰竭(LKENP,AARS2 相关),
- Pelizaeus-Merzbacher病,
- Pelizaeus-Merzbacher样疾病,
- 低髓鞘性脑白质营养不良,
- 伴有钙化和囊肿的脑白质营养不良 (LCC),
- 白质脑病伴共济失调疾病(LKPAT,CLCN2相关),
- L-2-羟基戊二酸尿症,
- 多糖体病,
- 甲基丙二酸血症伴高胱氨酸尿症,
- 尼曼拾取 C 型,
- 法尔病,
- 威尔逊氏病,
- 脑腱黄瘤病,
其他相关的 MeSH 术语
- 神经系统表现
- 内分泌系统疾病
- 脑部疾病
- 中枢神经系统疾病
- 病理过程
- 肿瘤
- 病理状况,解剖学
- 疾病属性
- 新陈代谢,先天性错误
- 消化系统疾病
- 神经行为表现
- 脱髓鞘疾病
- 神经退行性疾病
- 肝病
- 运动障碍
- 遗传退行性疾病,神经系统
- 脂质代谢紊乱
- 肾上腺疾病
- 智力残疾
- 遗传病,X连锁
- 溶酶体贮积病
- 基底节疾病
- 脑部疾病,代谢性,先天性
- 脑部疾病,代谢
- 遗传性中枢神经系统脱髓鞘疾病
- 脂质代谢,先天性错误
- 金属代谢,先天性错误
- 溶酶体贮积病,神经系统
- 脂肪沉积症
- 肾上腺功能不全
- 硫酸脂沉积症
- 过氧化物酶体疾病
- 先天性、遗传性和新生儿疾病和异常
- 病理状况、体征和症状
- 营养代谢疾病
- X连锁智力障碍
- 黄瘤病
- 未确诊的疾病
- 罕见病
- 先天性遗传病
- 神经系统疾病
- 代谢性疾病
- 脑白质病
- 肝豆状核变性
- 黄瘤病,脑腱病
- 鞘脂增多症
- 肾上腺脑白质营养不良
- 脑白质营养不良、异色症
- 脑白质营养不良,球形细胞
- Pelizaeus-Merzbacher病
- 囊肿
- 亚历山大病
- 法尔氏病
- Methylmalonic acidemia with homocystinuria
- Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
- 2-Hydroxyglutaricaciduria
其他研究编号
- MaNeNeND
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.